Publications by authors named "Yaiza Romero-Ventosa"
J Cancer Res Ther
November 2023
Article Synopsis
- Hepatocellular carcinoma, a leading cause of cancer deaths, is primarily treated with sorafenib, and this study evaluates its effectiveness and toxicity in real-world settings.
- A total of 36 patients were studied, revealing an average overall survival of 8.5 months and common adverse effects including constitutional, gastrointestinal, and dermatological issues.
- The results indicate that while survival outcomes in clinical practice align with clinical trials, the toxicity profile showed unexpected variations.
J Clin Pharm Ther
June 2021
Article Synopsis
- The study analyzed potential drug-drug interactions (pDDIs) in COVID-19 patients, focusing on those treated with specific medications during the first wave of the pandemic.
- Out of 350 patients, 62.3% had at least one pDDI, with significant impacts noted on the QTc interval in a small fraction of patients, indicating potential risks.
- While the incidence of pDDIs was high, clinically significant adverse effects were relatively low, highlighting the need for careful monitoring of drug interactions in COVID-19 treatment.
